Serial #87623102
LIVE

Serial Number

87623102

Owner

Replimune Limited

Attorney

Melanie Howard

Filing Date

Sep 26, 2017

Add to watchlist:

No watchlists yet
View on USPTO

Serial #87623102 Trademark

Serial Number: 87623102 • Registration: 5538932

Serial #87623102 is a trademark filed by Replimune Limited on September 26, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Replimune Limited (14 trademarks)

69 Innovation Dr., Milton Park, Abingdon
Oxfordshire OX144RQ , GB

Entity Type: 99

Trademark Details

Filing Date

September 26, 2017

Registration Date

August 14, 2018

Published for Opposition

May 29, 2018

Goods & Services

Biological preparations in the nature of viruses for the treatment of cancer, tumors, [ infectious, ] oncological [ , autoimmune, and immune system ] diseases and disorders; biological preparations in the nature of viruses for the treatment of cancer; biological preparations in the nature of viruses for inducing immune response; pharmaceuticals, namely, pharmaceutical preparations and pharmaceutical substances for the treatment of cancer, tumors, [ infectious, ] oncological [ , autoimmune, and immune system ] diseases and disorders; [ pharmaceuticals, namely, anti-infectives for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; ] pharmaceuticals for the treatment of cancer; pharmaceuticals preparations for inducing immune response; vaccines; immunotherapy products, namely, pharmaceutical products for the prevention and treatment of cancer, tumors, [ infectious, ] oncological [ , autoimmune, and immune system ] diseases and disorders [ ; gene therapy products, namely, therapeutics for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders ]

[ Pharmaceutical drug research and development services; research and development of vaccines and medicines; information, advisory and consultancy services relating to the aforesaid ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 31, 2025 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 31, 2025 C15P
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 30, 2025 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 30, 2025 C15A
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Jan 29, 2025 EROP
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Aug 1, 2024 PR23
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 1, 2024 APRE
TEAS SECTION 8 & 15 RECEIVED
Jan 16, 2024 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Aug 14, 2023 REM1
REGISTERED-PRINCIPAL REGISTER
Aug 14, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 29, 2018 NPUB
PUBLISHED FOR OPPOSITION
May 29, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 9, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 22, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 17, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 17, 2018 CRFA
ASSIGNED TO LIE
Apr 16, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 5, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 3, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jan 3, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jan 3, 2018 CNRT
ASSIGNED TO EXAMINER
Jan 3, 2018 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 3, 2017 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 30, 2017 NWOS
NEW APPLICATION ENTERED
Sep 29, 2017 NWAP